Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the JDRF lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
The focus of this event is ‘type 1 technology’ covering aspects such as access, choice, and everyday living with type 1 technology.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > For professionals > Policymakers
At JDRF, we are dedicated to making a positive impact on the lives of everyone living with type 1 diabetes by actively participating in advocacy work.
Our goal is to shape healthcare consultations regarding access to new treatments and technology. You can learn more about our efforts in influencing policies that affect people with type 1 by exploring our comprehensive policy papers.
A crucial aspect of our work involves actively engaging and responding to consultations from public bodies such as the National Health Service (NHS), the National Institute for Health and Care Excellence (NICE), and the UK and Devolved Governments.
We contribute real-life case studies, gather insights from academic experts and healthcare professionals, ensuring that the unique needs and challenges of people with type 1 diabetes are taken into account when making healthcare decisions and developing guidelines.
We regularly publish our policy positions on key issues related to type 1 diabetes. These positions are based on expert research, input from the type 1 community, and the valuable insights provided by individuals and professionals in the field. By making our positions publicly available, we aim to raise awareness and advocate for necessary changes that will enhance the lives of everyone living with type 1 diabetes.
We actively engage in efforts to influence government policies through briefings and meetings with Parliamentarians. By working closely with policymakers, we strive to ensure that the concerns and voices of the type 1 diabetes community are heard and addressed.
Through strategic advocacy, we aim to drive policy changes that enhance access to innovative treatments, support research funding, and improve overall healthcare for all individuals with type 1 diabetes.
Read how JDRF gives information and evidence to policymakers and healthcare bodies to inform policies, debates, and laws relating to type 1 diabetes.
View and download our reports and resources that can help you to make type 1 diabetes a priority for policymakers and healthcare professionals.
Read JDRF’s position on a range of issues including our position regarding animal research, telemedicine, access to type 1 technology, and ‘DIY’ technologies.
Our international research programme means that life-changing treatments and developments for type 1 diabetes are in clinical trials around the world.
We commissioned social research to understand the varying pandemic experiences of different people affected by type 1 diabetes in the UK. The experiences shared for the report depict an enormous withdrawal of NHS services during the pandemic, leading to starkly unequal access to type 1 diabetes care.
We wrote to the producers of the hit BBC show after they broadcast jokes about type 1 diabetes.
Parliamentary Inquiry chaired by our Global Health Ambassador, Rt. Hon Theresa May MP and Sir George Howarth MP, highlights the risks of type 1 diabetes-related eating disorders (T1DE).
In an historic advancement in the treatment of type 1 diabetes, the National Institute for Health and Care Excellence (NICE) today approves hybrid closed loop for the majority of people living with type 1 diabetes in England and Wales.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
